7-(Chloroquinolin-4-yl) Sulfanyl Derivatives, Optimization of the Synthesis, In Silico ADMET Profiling Studies, and Evaluation of the Biological Activity Against Leishmania mexicana.

Authors

Angelo Gelvez, Liesangerli Labrador-Fagúndez, Bruno G Stella, Sugeins Rivero, Yaniska Ramirez, Thalia Vidal, Nathalia Martinez-Sotillo, Alírica Suárez, Katiuska Chávez, Hegira Ramírez, Zuleyma Blanco, Joyce Gutiérrez, Jaime Charris, Gustavo Benaim

Published in

ChemMedChem. Volume 21. Issue 21. Nov 12, 2026.

Abstract

Leishmaniasis is a parasitic human infection that constitutes a major global health challenge due to limited therapeutic options, toxicity, resistance, and high costs of the drugs approved as therapy. In this study, a group of 7-chloroquinoline derivatives (5-12) was synthesized via an optimized route and evaluated against the human parasite Leishmania mexicana. Compounds were fully characterized and showed favorable in silico ADME/Tox profiles, including high predicted gastrointestinal absorption (>93%), although limited solubility and potential hepatotoxicity were observed for several derivatives. Biological assays demonstrated significant antileishmanial activity. Interestingly, intracellular amastigote assays revealed nanomolar potency and very high selectivity index (SI), with compound 12 exhibiting IC₅₀ = 2.5 nM (SI = 21.030) and compound 9 IC₅₀ = 5.2 nM (SI = 7.384). Mechanistic studies demonstrated concentration-dependent mitochondrial membrane depolarization and acidocalcisome alkalinization. Since these two organelles are both involved in bioenergetics and in parasite intracellular Ca²⁺ homeostasis, the results support the notion that intracellular Ca²⁺ disruption is an essential target for different drug actions. Overall, these findings support a multitarget mechanism and position these quinoline derivatives as promising chemical scaffolds for the development of improved antileishmanial strategies.

PMID:
42956361
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.